Reproduction 3.0
By Leah Ramsay,
Berman Institute of Bioethics Bulletin
| 02. 26. 2015
Untitled Document
The House of Lords in the United Kingdom voted to allow fertility clinics to apply for licenses to perform “mitochondrial donation” IVF procedures on Tuesday. The UK is the first nation to explicitly allow the procedure, which it had previously banned; the resulting child would have genetic material from her parents and also from a donor of mitochondrial DNA (mtDNA), with the aim of avoiding transmission of debilitating mitochondrial disease from mother to child. The procedure has never been performed in humans.
Meanwhile, in the United States, the Food and Drug Administration (FDA) is considering clinical trials to test the procedure in humans, and is conducting inquiry into safety as well as ethical and social policy considerations.
The procedure is considered controversial because some say it would cross the “germ line,” or make a permanent, engineered change to the DNA that is passed down from mother to child. Previously this has been seen as an ethical line not to be crossed, but recently scientists and ethics scholars have come out in favor of its potential to allow...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...